Tuloxxin 100 mg/ml solution for injection for cattle, pigs and sheep
Tuloxxin 100 mg/ml solution for injection for cattle, pigs and sheep
Authorised
- Tulathromycin
Product identification
Medicine name:
Tuloxxin 100 mg/ml solution for injection for cattle, pigs and sheep
Tuloxxin, 100mg/ml, Injekční roztok
Active substance:
- Tulathromycin
Target species:
-
Sheep
-
Pig
-
Cattle
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Tulathromycin100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Sheep
-
Meat and offal16day
-
-
Pig
-
Meat and offal13day
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offal22day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA94
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Available in:
-
Czechia
Package description:
- Type I clear glass bottle of 50 ml with Type I chlorobutyl/butyl film laminated rubber stopper and aluminium cap with plastic tear/flip-off tab, in a cardboard box.
- Type I clear glass bottle of 100 ml with Type I chlorobutyl/butyl film laminated rubber stopper and aluminium caps with plastic tear/flip-off tab, in a cardboard box.
- Type I clear glass bottle of 250 ml with Type I chlorobutyl/butyl film laminated rubber stopper and aluminium cap with plastic tear/flip-off tab, in a cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- TAD Pharma GmbH
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/027/19-C
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0396/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet